Company Profiles

driven by the PitchBook Platform

Aelix Therapeutics

Description

Developer of a new therapeutic vaccine designed to help people with HIV. The company's new therapeutic vaccine is basedon a disruptive design of a T-cellimmunogen that is able to elicit a strong broad and focused responseagainst HIV and has the potential to radically transform the treatment of HIV infection, enabling patients to get cured from HIV diseases.

2015

Founded

PRIVATE

Status

Series A

Latest Deal Type

$13M

Latest Deal Amount

$13M

Total Amount Raised

3

Investors

Description

Developer of a new therapeutic vaccine designed to help people with HIV. The company's new therapeutic vaccine is basedon a disruptive design of a T-cellimmunogen that is able to elicit a strong broad and focused responseagainst HIV and has the potential to radically transform the treatment of HIV infection, enabling patients to get cured from HIV diseases.

Website:

www.aelixtherapeutics.com

Ownership Status

Privately Held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Biotechnology

Other Industries

Drug Delivery
Pharmaceuticals

Primary Office

Parc Científic de Barcelona Carrer Baldiri i Reixac 4-8 08028 BarcelonaSpain +34 93 403 1339
    Request a free trial to the PitchBook Platform
    You're viewing a free company profile from the PitchBook Platform. To explore Aelix Therapeutics's full profile, request a free trial.

    Aelix Therapeutics Valuation and Funding

    Request access
    Deal TypeDateAmountRaised to DatePost-ValStatusStage

    Aelix Therapeutics Investors (3)

    Request access
    Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
    Seat
    Contact
    Info
    Caixa Capital RiscCorporate Venture CapitalMinority000 0000000 0000
    Johnson & Johnson Innovation - JJDCCorporate Venture CapitalMinority000 0000000 0000
    Ysios CapitalVenture CapitalMinority000 0000000 0000
    Caixa Capital Risc Corporate Venture Capital
    Johnson & Johnson Innovation - JJDC Corporate Venture Capital
    Ysios Capital Venture Capital

    Aelix Therapeutics Executive Team (6)

    NameTitleBoard
    Seat
    Contact
    Info
    José Luis CaberoChief Executive Officer
    Christian Brander Ph.DChief Scientific Officer & Co-Founder
    Jordi NavalCo-Founder & Board Member
    Ventura ClotetCo-Founder & Board Member
    Josep Maria GatellCo-Founder
    José Luis Cabero Chief Executive Officer
    Christian Brander Ph.D Chief Scientific Officer & Co-Founder
    Jordi Naval Co-Founder & Board Member
    Ventura Clotet Co-Founder & Board Member
    Josep Maria Gatell Co-Founder

    Aelix Therapeutics Board Members (6)

    NameRepresentingRoleSinceContact
    Info
    Jeanne BolgerJohnson & Johnson Innovation - JJDCVice President, Venture Investments000 0000
    Jordi NavalAelix TherapeuticsCo-Founder & Board Member000 0000
    José Antonio MesaCaixa Capital RiscInvestment Director000 0000
    Karen WagnerYsios CapitalGeneral Partner000 0000
    Philippe Monteyne Ph.DSelfBoard Member000 0000
    Jeanne Bolger Vice President, Venture Investments Johnson & Johnson Innovation - JJDC
    Jordi Naval Co-Founder & Board Member Aelix Therapeutics
    José Antonio Mesa Investment Director Caixa Capital Risc
    Karen Wagner General Partner Ysios Capital
    Philippe Monteyne Ph.D Board Member Self
    Request full access to PitchBook